Status:

WITHDRAWN

Pain Levels and Opioid Usage in Three Nerve Block Cohorts in Primary TKA

Lead Sponsor:

University of Louisville

Conditions:

Knee Arthropathy

Eligibility:

All Genders

22-89 years

Phase:

NA

Brief Summary

The primary objective of this study is to compare effect of combined block of ACB (adductor canal block) with IPACK (Interspace between the Popliteal Artery and the Capsule of the posterior Knee) bloc...

Eligibility Criteria

Inclusion

  • Patient is indicated for a primary, unilateral TKA secondary to osteoarthritis.
  • Patient age is 22-89 at time of TKA surgery.
  • Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization document.
  • Patient is able to read and speak English.

Exclusion

  • Patient is under the age of 22 or over the age of 89.
  • Patient's primary diagnosis is not osteoarthritis (e.g. post-traumatic arthritis).
  • Patient is scheduled to undergo a bilateral TKA surgery.
  • Patient is unable to read and speak English.

Key Trial Info

Start Date :

April 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2020

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04292392

Start Date

April 6 2020

End Date

September 30 2020

Last Update

November 4 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jewish Hospital

Louisville, Kentucky, United States, 40202